Back
EPAM Systems, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
34
EPAM
EPAM Systems, Inc.
Last Price:
$207.53
Seasonality Move:
-0.13%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$64.75
Seasonality Move:
25.93%
Sell
34
EPAM Systems, Inc. (EPAM)
is a Sell
Is EPAM Systems, Inc. a Buy, Sell or Hold?
-
The current EPAM Systems, Inc. [EPAM] share price is $204.33. The Score for EPAM is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPAM Stock Price Chart
What is EPAM Systems, Inc.'s stock price today?
-
The EPAM Systems, Inc. share price today is $204.33The current trend is moderately bullish and EPAM is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $67.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
EPAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.64 | Buy |
| Relative Strength Index (14 RSI): | 65.84 | Buy |
| Chaikin Money Flow: | -693529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (180.81 - 205.77) | Buy |
| Bollinger Bands (100): | (149.65 - 185.59) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.86 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -124010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.34 - 86.38) | Sell |
| Bollinger Bands (100): | (44.81 - 88.99) | Buy |
EPAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.3 | Sell |
| 20-day SMA: | 196.81 | Buy |
| 50-day SMA: | 175.38 | Buy |
| 200-day SMA: | 169.38 | Buy |
| 8-day EMA: | 206.08 | Sell |
| 20-day EMA: | 197.88 | Buy |
| 50-day EMA: | 183.23 | Buy |
| 200-day EMA: | 179.11 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Sell |
| 20-day SMA: | 80.22 | Sell |
| 50-day SMA: | 82.77 | Sell |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 74.03 | Sell |
| 20-day EMA: | 77.79 | Sell |
| 50-day EMA: | 77.58 | Sell |
| 200-day EMA: | 56.47 | Buy |
EPAM Systems, Inc. Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.02 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
EPAM Systems, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||